To this end, we interrogated separately low-grade gliomas and GBMs, and stratified samples according to the expression of ZNF423. This analysis revealed a significant direct correlation between ZNF423 expression and survival in low-grade gliomas (Fig. 4b), with high expression associated to longer survival. Here, ZNF423 is linked to central nervous system cancer.